v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net loss $ (35,782) $ (17,689)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 13,917 12,992
Amortization of operating lease right-of-use assets 4,608 3,786
Accounts receivable allowances 1,213 1,492
Stock-based compensation 89,095 68,115
Change in fair value of contingent consideration 506 (1,004)
Deferred income taxes (501) (385)
Foreign currency impact from dissolution of subsidiary 799 0
Asset impairments 1,351 0
Other 146 336
Changes in operating assets and liabilities:    
Accounts receivable 8,769 31,438
Unbilled receivables, current 7,404 (4,266)
Prepaid expenses and other assets 254 (6,701)
Deferred commissions (3,842) 696
Accounts payable and accrued liabilities (12,561) (1,192)
Deferred revenue, net 22,818 (8)
Operating lease liabilities (4,911) (3,684)
Other liabilities 7,309 1,260
Net cash provided by operating activities 100,592 85,186
Cash Flows from Investing Activities:    
Purchases of property and equipment (1,784) (795)
Capitalized internal-use software costs (6,468) (5,495)
Business combinations, net of cash acquired (9) (897)
Purchase of strategic investments (2,990) 0
Net cash used in investing activities (11,251) (7,187)
Cash Flows from Financing Activities:    
Proceeds from stock option exercises 9,358 36,139
Proceeds from employee stock purchase plan 2,153 1,970
Payments related to tax withholding for vested equity awards (14,408) 0
Payments of contingent consideration and holdback associated with acquisitions (1,669) (2,410)
Repurchases of common stock (250,146) 0
Net cash (used in) provided by financing activities (254,712) 35,699
Effect of foreign currency exchange rate changes on cash and cash equivalents (915) 1,138
Net (decrease) increase in cash, cash equivalents and restricted cash (166,286) 114,836
Cash, cash equivalents and restricted cash - beginning of period 313,309 208,570
Cash, cash equivalents and restricted cash - end of period 147,023 323,406
Reconciliation of cash, cash equivalents and restricted cash to the unaudited condensed consolidated balance sheets:    
Cash and cash equivalents 146,823 323,206
Restricted cash 200 200
Total cash, cash equivalents and restricted cash 147,023 323,406
Supplemental Disclosures of Cash Flow Information:    
Cash paid for income taxes, net of tax refunds 586 2,460
Non-Cash Investing and Financing Activities:    
Purchases of property and equipment in accounts payable and accrued liabilities 347 183
Capitalized internal-use software costs in accounts payable and accrued liabilities 278 751
Contingent consideration and acquisition holdbacks in accounts payable, accrued expenses and other liabilities 0 3,036
Stock-based compensation expense capitalized in internal-use software costs, net 1,297 233
Accrued tax withholding for vested equity awards 865 0
Excise tax on repurchases of common stock $ 919 $ 0